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Abstract
Background: Mitogen-activated protein kinases (MAPK) signaling affects many processes, some of which have
different outcomes in the same cell. In Arabidopsis, activation of a MAPK cascade consisting of YODA, MKK4/5 and
MPK3/6 inhibits early stages of stomatal developmental, but the ability to halt stomatal progression is lost at the
later stage when guard mother cells (GMCs) transition to guard cells (GCs). Rather than downregulating cascade
components, stomatal precursors must have a mechanism to prevent late stage inhibition because the same MKKs
and MPKs mediate other physiological responses.
Results: We artificially activated the MAPK cascade using MKK7, another MKK that can modulate stomatal development,
and found that inhibition of stomatal development is still possible in GMCs. This suggests that MKK4/5, but not MKK7,
are specifically prevented from inhibiting stomatal development. To identify regions of MKKs responsible for cell-type
specific regulation, we used a domain swap approach with MKK7 and a battery of in vitro and in vivo kinase assays. We
found that N-terminal regions of MKK5 and MKK7 establish specific signal-to-output connections like they do in other
organisms, but they do so in combination with previously undescribed modules in the C-terminus. One of these
modules encoding the GMC-specific regulation of MKK5, when swapped with sequences from the equivalent region of
MKK7, allows MKK5 to mediate robust inhibition of late stomatal development.
Conclusions: Because MKK structure is conserved across species, the identification of new MKK specificity modules and
signaling rules furthers our understanding of how eukaryotes create specificity in complex biological systems.
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Background
MAPKs have strategic roles in signal processing, in me-
diating stress responses, and in guiding cell fate transi-
tions and development [1–4]. MAPK networks consist
of a three-tiered cascade whose kinases—MAPK kinase
kinase or MKKK, MAPK kinase (Mapk/Erk kinases or
MEK in animals, MKK in Arabidopsis) and MAPK
(MPK in Arabidopsis) sequentially phosphorylate and
activate each other upon signal perception. Downstream
effectors may respond to MPK-mediated phosphorylation
by changes in protein activity, localization or stability, and
many of these alterations ultimately alter transcriptional
programs. The MKK level is a bottleneck in many species.
In humans, at least 25 MKKKs activate the 7 MEKs, which
lie upstream of 14 MAPKs [1]. In Arabidopsis thaliana,
more than 60 MKKKs are predicted upstream of 10 MKKs
and 23 MPKs [5]. Evidence exists that MKKs can activate
more than one MPK, and a given MPK may have more
than one upstream MKK [6]. Intuitively, this arrangement
could facilitate signal integration, as multiple signals could
converge on a single effector. The use of common com-
ponents, however, could also lead to erroneous cross-
activation.
When expressing multiple MAPK network components
and responding to multiple sources of information, how
do cells generate an appropriate output to a particular
signal? One strategy is to make downstream effectors
available in only certain cells [7] or under certain condi-
tions [8–10]. Alternatively, signaling networks can be insu-
lated through the use of scaffolds, subcellular partitioning
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of signaling complexes, and by varying signal amplitude or
duration [1, 5, 11–14]. Some MAPK network components
encode regions that allow them to establish these connec-
tions or localizations. For instance, the animal MEK1/2
uses its proline-rich sequence (PRS) to bind the scaffolds
Kinase Suppressor of Ras (KSR) and Mek Partner 1 (MP1).
Binding to MP1, in particular, mediates endosomal
localization [15–17]. Several human MEKs and all Ara-
bidopsis MKKs lack a PRS, however, leaving questions
about how these smaller MKKs are correctly assembled
into restricted MAPK networks.
In Arabidopsis, MAPK signaling has fundamental roles
in development and organogenesis [18, 19] including in
the formation of stomata, the structures in the epidermis
of plants that regulate gas exchange [20, 21]. Because of
this central role of MAPK signaling in development,
studying how this cascade regulates particular cell fate
decisions with traditional genetic approaches is quite
challenging. New strategies that dissect specific responses
in selected tissues must be designed to replace analysis of
mutants with such complex, interlinked phenotypes. Such
strategies include the use of inducible or cell type-specific
promoters and constitutively active (CA) or dominant
negative variants of MAPK components. Although these
variants do not exist in nature, they mimic situations of
cell type-specific regulation of the MAPK cascade. Previ-
ously, we used a systematic study of cell stage-specific re-
sponses to MAPK activation and revealed that stomatal
precursors have mechanisms to limit certain cellular out-
puts and generate MKK-specific responses [22, 23]. Only
four of the 10 MKKs -MKK4, MKK5, MKK7 and MKK9-
have any capacity to influence stomatal development dur-
ing lineage initiation, guard mother cell (GMC) commit-
ment and/or guard cell (GC) formation (for simplicity,
only MKK5 and MKK7 are shown in Fig. 1). Expression of
any of these CA-MKKs strongly inhibits stomatal forma-
tion in early development (Fig. 1a, b and c). At the last
stage of development, however, MKK4 and MKK5 lose
their ability to inhibit stomatal formation (Fig. 1d and e).
MKK7 and MKK9 activation, in contrast, results in sto-
matal clustering (Fig. 1d and f ). Loss of function studies
with MKK4 and MKK5 indicate that these kinases are
Fig. 1 Schematic of stomatal lineage, indicating stages where MKK activation leads to similar and divergent outputs (based on [22]). Diagrams of
MAPK signaling cascades, with each colored circle representing a different kinase level; circles are labeled with relevant kinase number, with orange
circle representing MPK of unknown identity. Constitutive activation of YDA (MKKK), MKK5 or MKK7 inhibits stomatal lineage initiation (a, SPCH and
MUTE stages). Late in the lineage (d, FAMA stage) YDA and MKK7, but not MKK5, activation leads to stomatal proliferation via an unidentified
MPK. b, c, e, f Tracings of phenotypes resulting from activation of kinases. In (b–c), constitutively active MKK5 (MKK5DD) or MKK7 (MKK7ED)
inhibit initiation (division of meristemoid mother cell (MMC) into meristemoid (M)) and lineage progression (conversion of M into guard
mother cell (GMC)). In (e–f), MKK5DD has no effect (e, WT numbers and distribution of stomata in green), but MKK7ED induces guard cell (GC)
overproliferation and clustering (f). Stages are referred to as SPCH, MUTE and FAMA after the promoters to drive expression of MAPK network
components [22]. YDA, YODA; 5, MKK5; 7, MKK7; 3/6, MPK3 and MPK6
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endogenously required to limit stomatal production
[21], but the MKK7/9 significance is unclear as mkk9
single mutants do not affect stomata and in the recent
report of true loss of function mutations in mkk7 mu-
tants no stomata phenotype was described [19]. MKK4/
5’s endogenous role in limiting stomatal production in
early stages, but not in late stomatal lineage cells, pro-
vides an excellent test case for examining how cell
identity may interface with signaling response.
In this study, we created a quantitative phenotypic
analysis pipeline that revealed a previously underappre-
ciated capacity for late stage stomatal lineage cells to be
inhibited by MAPK signaling. Then, taking advantage of
divergent responses to constitutively activated MKK5
and MKK7, we implemented a protein engineering ap-
proach to identify structural domains in MKK5 that are
responsible for its stage-specific behaviors. We found
that MKK N-terminal regions establish specific signal-
to-output connections, much like they do in other or-
ganisms [24], but this requires coordination with previ-
ously unexplored regions in the C-terminus. We also
found that a minimal domain in the C-terminus encodes
the basis for MKK-specific regulation. The location of
specificity modules within the plant proteins corresponds
to regions in which their human homologues display high
sequence diversity, suggesting that these regions may con-
tribute to specificity in many situations. Given the global
conservation of MAPK signaling, our findings in the com-
plex multicellular context of plant development may offer
insights into general mechanisms of signaling specificity
in complex biological systems.
Results
Stomatal development is inhibited by MAPK activation at
the FAMA stage
To carefully define the range of phenotypes in our system,
we re-analyzed the inhibitory effect of CA-MKK expres-
sion in FAMA stage cells (Fig. 1d) using more sensitive
and quantitative measurements than in our previous stud-
ies [22, 23]. For simplicity, we selected one representative
MKK from each MKK4/5 and MKK7/9 pair as previous
studies showed that MKK4 mirrors MKK5 activity, and
MKK7 mirrors MKK9 activity, in every stage of stomatal
development [22, 23]. Because MKKs were to be analyzed
in planta, we selected MKK5 and MKK7, both of which
can be easily detected as YFP fusion proteins, thereby
providing a control for expression. FAMA promoter
(FAMApro) was used to drive the expression of consti-
tutively active MKKs which are made dominantly active
by replacing the regulatory S/T residues of the activation
loop with phosphomimetic D/E residues (MKK5DD =
MKK5T215D,S221D and MKK7ED =MKK7S193E,S199D) [22, 25].
To be able to observe all epidermal phenotypes
produced by different MKK expression levels, such as
inhibition of stomatal development and stomatal clustering,
phenotypes were quantified in cotyledons of independent
primary transformants (T1 s in Table 1, Fig. 2a). We paid
special attention to evidence of seedling lethality, a typical
result of inhibition of stomatal development. Previously,
expression of MKK7ED was shown to lead to stomatal
hyperproliferation [22], and we could confirm that result:
54% T1 s showed large stomatal clusters (Fig. 2a and b,
Table 1); however, 26% were WT (most of which showed
no YFP signal) and 20% had stomatal precursors that failed
to complete their development into GCs (Fig. 2a and b,
Inhibited). This third class died as seedlings. Among
MKK5DD-YFP transformants, there were no seedling
lethals: 76% T1 s had a phenotype indistinguishable
from controls (Fig. 2b, Table 1) and 24% exhibited one
to three small clusters (2–3 stomata in contact) per 0.
32 mm2.. Among control seedlings grown in parallel, ~
8% exhibited similar small clusters (Table 1). Phenotype
distributions for MKK5DD-YFP and MKK7ED-YFP were
statistically different in Chi-squared test of independence
(p < 0.05).
These results indicate that MAPK activation through
MKK7ED, besides driving stomatal clustering, can also
lead to inhibition of stomatal development at the FAMA
stage. The failure of MKK5DD to inhibit this stage
transition is puzzling, since MKK5 is the endogenous
kinase, whereas MKK7 is not normally expressed in
FAMA stage cells [26]. Moreover, MKK5DD is an effective
inhibitor of earlier stages [22] and MKK4MKK5RNAi lines
show excess mature GCs [21]. Also, when compared to
MKK7ED, MKK5 exhibits stronger interactions with
MPK3/6 in Y2H (Additional file 1: Figure S1) and stronger
kinase activity in vitro (Additional file 2: Figure S2). MKK5,
therefore appears to be subject to an additional level of in
vivo regulation that blocks its inhibitory effect, while
MKK7 seems to escape this regulation. We reasoned that
structural differences between MKK5 and MKK7 could be
probed to define the nature and the source of this
differential regulation.
Predicted tertiary structures of MKK5 and MKK7 suggest
sources of MKK identity and specificity
We reasoned that the domains most likely to confer the
FAMA-stage differential responses would be surface ex-
posed (thus available for interactions with partners) and
would exhibit the greatest structural and sequence diver-
gence among MKKs. To facilitate the identification of
such regions, we modeled plant MKK folds based on the
X-ray crystal structures of human orthologs MEK1 and
MEK2 using I-Tasser [27] (Fig. 3) and used structural in-
formation from several other mammalian kinases [28–31]
to identify conserved features.
Structural alignment of MKK5 and MKK7 to mam-
malian kinases confirmed the conservation of the
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kinase fold [31] (Fig. 3a and b, with primary sequence
in Additional file 3: Figure S3A). The core catalytic do-
mains of MKK5 and MKK7 are quite similar, but the
N- and C-termini are variable. This is similar to MEK1/2,
where catalytic domains are similar and well resolved, but
the flanking N- and C-terminal extensions and a region
containing the PRS are not. In addition, MKK5 possesses,
but MKK7 completely lacks, sequences at positions
comparable to the C-terminal extension in MEK1/2
(Additional file 3: Figure S3C). Previously, we showed
that this C-terminal extension does not contribute to
MKK5 activity or specificity, but that N-termini have
an important role in MKKs activities, possibly through
the presence of D-docking domains that mediate inter-
actions with downstream MPKs [23].
In addition to the distinct C-terminal distal region
(CDR), divergent surface-exposed regions of the plant
MKKs include a C-terminal proximal region (CPR) between
conserved subdomains VIII and X (Fig. 3, Additional files 3
and 4: Figures S3 and S4). The CPR contains two loops.
Loop A starts immediately downstream of the YM(S/A)PER
sequence, a MKK signature [2], and ends before the highly
conserved α-helix F. The sequence of loop A is similar be-
tween kinases with identical functions and different between
kinases with divergent functions in both Arabidopsis and
humans (Additional file 4: Figure S4). For example, loop A
in MKK4 and MKK5 is identical, whereas it differs between
MKK5 and MKK7. Loop B is downstream of α-helix F and
displays a high tolerance for sequence variability (Fig. 3,
Additional files 3 and 4: Figures S3 and S4). Among CMGC
(Cyclin-dependent kinases, MAPK, Glycogen synthase kin-
ase and Cyclin-dependent kinase-like kinase) group kinases,
loop B contains an insert that binds interacting proteins
[29], and a different insert in MEK1/2 mediates binding to
MAPK scaffolds MP1 and KSR [15, 32]. This region is
shorter in plant MKKs (making them resemble human
MEK3-MEK7), but the sequence divergence among MKKs
is consistent with this loop being a specificity or iden-
tity determinant. It is therefore a prime region to target
in our dissection of specificity.
N-termini link specific MKKs to specific phenotypes
Different in vivo behaviors of MKK5DD and MKK7ED
make it possible to begin to correlate unique sequences
Table 1 Quantification of in vivo and in vitro phenotypes conferred by chimeras




FAMA stage phenotypes (as percentage
of total T1 seedlings)
KI-MPK3 KI-MPK6 n % n Inhibited WT GC clusters
AVG SE AVG SE Small Large Total
YFP control 24 0.00 91.67 8.33 0.00 8.33
MKK5DD 34.485 9.052 38.259* 2.308 69 78.26 25 0.00 76.00 24.00 0.00 24.00
MKK7ED 6.836 4.808 10.867 5.726 93 100.00 50 20.00 26.00 0.00 54.00 54.00
N7-MKK5DD 5.500 1.894 21.448 9.176 75 26.67 125 8.80 32.00 48.80 10.40 59.20
N5-MKK7ED 15.889 7.052 35.235* 1.457 22 86.36 47 93.62 6.38 0.00 0.00 0.00
MKK5DD-C7 13.888 9.753 25.666* 2.530 47 87.23 44 65.91 29.55 4.55 0.00 4.55
MKK5DD-7A 45.980 22.674 26.287 4.947 114 12.28 98 0.00 97.96 2.04 0.00 2.04
MKK5DD-7B 46.746 22.671 38.718* 0.750 20 10.00 70 50.00 50.00 0.00 0.00 0.00
MKK7ED-C5 3.877 2.091 0.728 0.148 43 13.95 19 0.00 78.95 21.05 0.00 21.05
MKK7ED-CDR5 2.451 1.242 1.303* 0.312 89 98.81 30 96.67 3.33 0.00 0.00 0.00
MKK7ED-CPR5 15.844 11.444 5.904 2.422 105 0.00 36 2.78 91.67 5.56 0.00 5.56
MKK7ED-5A 15.440 12.606 5.219 4.017 125 88.00 54 81.48 14.81 3.70 0.00 3.70
MKK7ED-5B 7.238 4.545 1.317 0.200 198 16.67 60 0.00 48.33 40.00 11.67 51.67
N7-MKK5DD-C7 3.526 1.153 2.411 0.915 91 54.95 43 2.33 13.95 13.95 69.77 83.72
N5-MKK7ED-C5 4.724 2.876 1.439 0.673 51 72.55 46 0.00 71.74 28.26 0.00 28.26
MPK3, not shown 49 0.00 50 0.00 82.00 18.00 0.00 18.00
MPK3D193G/E197A 18 0.00 52 0.00 80.77 19.23 0.00 19.23
MPK3T119C, not shown 43 0.00 89 0.00 86.52 13.48 0.00 13.48
MPK6, not shown 122 0.00 45 0.00 84.44 15.56 0.00 15.56
MPK6D218G/E222A 6 100.00 27 0.00 77.78 22.22 0.00 22.22
MPK6Y144C, not shown 35 0.00 21 0.00 90.48 9.52 0.00 9.52
Kinase activity is determined in triplicates with the exception of those marked with “*” that were done in duplicates. Averages (AVG) and Standard Errors (SE) are
represented in the table. Phenotypic categories for FAMA stage phenotypes are described in Methods
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and structures with unique functions. Informed by the
structural analysis, we made chimeric MKKs based on
dividing the MKKs into N- terminal (N), kinase domain
(MKK) and C-terminal (C) regions, and further dividing
the C domain into CDR and CPR (and within CPR,
Loop A and B) (Fig. 3). To assay the function of these
domains, we measured the phenotypes induced by chi-
meras at the FAMA stage in T1 s and compared to those
obtained for intact MKK5DD and MKK7ED. Expression
and subcellular localization of YFP-tagged MKKs was
verified by confocal microscopy. We predicted that cer-
tain domain combinations could result in non-functional
chimeras. Because expression of MKK5DD (Fig. 4a) and
non-functional chimeras would give essentially the same
phenotype at the FAMA stage (no effect on stomatal de-
velopment), it was important to discriminate MKK5DD-
like chimeras from non-functional chimeras. We took two
approaches to verify that kinases were still active. First, we
measured the intrinsic kinase activity against MPK3/6
in in vitro kinase assays (Additional file 2: Figure S2).
Second, we took advantage of the fact that both
MKK5DD and MKK7ED drive robust inhibition of
stomatal initiation at the SPCH stage [22] to create an
in vivo assay for kinase activity. We expressed the
chimeras at the SPCH stage and quantified the degree
of inhibition of stomatal initiation (Table 1).
To characterize the role of the N-terminus in MKK5, we
replaced it with the N-terminus of MKK7 (N7-MKK5DD)
and the chimera was expressed in FAMA stage cells. ~
59% of T1 transformants produced stomatal clusters
(Fig. 4b and g), though clusters were smaller than
those generated by MKK7ED. In addition, 9% of T1
transformants showed inhibition of stomatal formation
(Fig. 4g). We also noticed that N7-MKK5DD partially
relocalized to mitochondria (Fig. 4b) similar to MKK7ED
[23]. Our in vitro and in vivo controls for activity both
indicated that N7-MKK5DD was less active than intact
MKK5DD; only ~ 27% of T1 s inhibited stomatal initiation
(Fig. 4h) and in vitro kinase activity was lower, especially
towards MPK3 (Fig. 4i). This dramatic output alteration
(aphenotypic MKK5DD to a weak MKK7ED-like behavior)
suggests that the N-terminus is more than just a structural/
regulatory region required for protein activity. Instead, it
appears to channel the MKK towards specific phenotypic
outcomes. This specificity behavior resembles that observed
in yeast where MKKs involved in other cellular processes
were engineered to interact with components of the mating
pathway, but were only able to transduce a mating signal
when their N-termini were replaced with the N-terminus
from Ste7, the mating specific MKK [24].
If the N-terminus enforces MKK specific activities,
then replacement of N7 by N5 in MKK7ED should reveal
the endogenous response to MKK5 activation. With the
N5-MKK7ED chimera we found efficient inhibition of
lineage initiation at the SPCH stage and a normal ability
to phosphorylate MPK3 and MPK6 in vitro (Fig. 4h and i).
Like MKK5DD the chimera was cytoplasmic localized
(compare A and C in Fig. 4). Unlike MKK5DD, N5-
MKK7ED completely inhibited GC production (Fig. 4c
and g). Thus, with this manipulation, we were finally able
to recapitulate the stomatal lineage inhibition phenotype
we had expected from MKK5DD based on its ability to
inhibit stomatal development at earlier stages [22] and the
loss of function stomatal cluster phenotype [21].
Loop B prevents MKK5DD from inhibiting stomata
formation at the FAMA stage
Demonstrating that development of FAMA-stage cells
could be inhibited, however, raised the question of why
intact MKK5DD is unable to do so. We hypothesized
that sequences in the MKK5 C-terminus act as negative
regulatory regions. To test this idea, we first replaced the
entire C-terminal region of MKK5, creating MKK5DD-C7.
FAMA-stage expression did result in a partially penetrant
Fig. 2 Differences phenotypic output between MKK5 and MKK7. a
Micrographs of phenotypes resulting from FAMA-stage expression of
MKK5DD and MKK7ED: precursors exit the stomatal lineage and do
not make GCs (arrowheads); Normal (single stomata comprised of
two GCs) or small (2–3) or large (4+) clusters of adjacent stomata
resulting from overproliferation of precursors before they become
GCs. Scale bars are 10 μm. b Quantification of phenotypes, percentage
of seedlings showing one of four phenotypes. >19 independent
transformants were scored per genotype and stage (Ns reported in
Table 1). 35Spro:YFP was used as a negative control (see Methods).
Error bars correspond to 95% confidence intervals
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inhibition of stomatal formation where inhibited precur-
sors coexisted with normal stomata (Fig. 4d and g).
MKK5DD-C7 displayed high activity in SPCH-stage
lineage inhibition (Fig. 4h), but was less efficient than
MKK5DD in in vitro kinase assays, particularly towards
MPK3 (Fig. 4i). Because previously reported MKK5
deletions in the CDR portion of the C-terminus did not
significantly change MKK5DD activities [23], we reasoned
that putative regulatory regions were located in the CPR.
The largest sequence differences between C5 and C7
reside in loop A and B in the CPR. Substitution of loop
A (MKK5DD-7A) resulted in a chimera that did not
affect stomatal development at the FAMA stage (Fig. 4e
and g), but substitution of loop B (MKK5DD-7B) led to
inhibition of stomatal formation at high frequency
(Fig. 4f and g). This result suggests that MKK5’s loop B
is a region that blocks MKK5 from participating in
stomatal inhibition at the FAMA stage. Interestingly,
SPCH stage activity was markedly reduced for both
chimeras (Fig. 4h), but in vitro activities of MKK5DD-
7A and MKK5DD-7B were at least as high as that of
MKK5DD (Fig. 4i). These observations suggest that
MKK5DD-7A and MKK5DD-7B are catalytically active
kinases but cannot generate appropriate signals in vivo.
Loop B is required for robust MKK7ED activity
If there was truly a discrete domain of MKK5 that was
subject to negative regulation, then transferring it to
MKK7ED should dampen the stomatal clustering phenotype
at the FAMA stage (Fig. 5a). We initially swapped the entire
C-terminus, and the resulting MKK7ED-C5 only produced
normal stomata, similarly to MKK5DD (Fig. 5b and g). This
could suggest that C5 is able to block MKK7 inhibitory
function at FAMA stage. However, monitoring other
indicators of MKK activity (SPCH stage lineage inhibition
and in vitro phosphorylation of MPK3 and MPK6)
suggested that C7 was essential for overall activity (Fig. 5h
and i). Thus this phenotype is the result of creating a
generally inactive MKK7 chimera, more than an effect due
to the presence of MKK5 regulatory sequences. Thus, we
split C5 into CDR5 and CPR5, and determined if we could
restore MKK7ED activity in vitro and in the SPCH stage.
Activity was restored in MKK7ED-CDR5: this chimera
completely inhibited lineage initiation at the SPCH stage
and was indistinguishable from MKK7ED in in vitro kinase
assays (Fig. 5h and i). Rather than decreasing MKK7ED
function, however, MKK7ED-CDR5 had a strikingly
stronger inhibitory effect on stomatal development at
the FAMA stage than MKK7ED (Fig. 5c and g). In fact, it
resembled the strong phenotype produced by N5-MKK7ED
(Fig. 4c). This implies that CDR5, like N5, channels MKK
activity to inhibition of stomatal development. In contrast,
MKK7ED-CPR5 was largely inactive at both SPCH
and FAMA stages (Fig. 5d and g), and in in vitro
phosphorylation assays against MPK3 and MPK6 (Fig. 5h
and i), indicating that CPR7 is necessary for MKK7ED
catalytic activity.
So far, the domains from MKK5 that dampened
MKK7ED activity at the FAMA stage also decreased the
activity of the chimeras in vitro and at the SPCH stage
(MKK7ED-C5 and MKK7ED-CPR5). From these results,
it appears that the CPR region is important for MKK7ED
Fig. 3 Differences in protein structure between MKK5 and MKK7. a–b Schematic and predicted structures of MKK5 (blue) and MKK7 (red). CPR, C-terminal
proximal region. CDR, C-terminal Distal Region. Four regions important for this study (N-termini, Loop A, Loop B and the C-termini) are bolded. Conserved
α helices A, F and G are labeled in grey
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catalytic activity and thus we created smaller domain swaps
(loops A and B) to attempt to transfer negative regulatory
sequences from MKK5 into MKK7ED without affecting
kinase functionality. MKK7ED-5A and MKK7ED-5B were
active in vivo (inhibited lineage initiation at the SPCH
stage, Fig. 5h) and in vitro (phosphorylated MPK3/6,
Fig. 5i), although to different degrees. At the FAMA
stage, MKK7ED-5A inhibited stomatal formation to a
greater extent than MKK7ED (Fig. 5e and g). This behavior
is similar to N5-MKK7ED (Fig. 4c) and MKK7ED-CDR5
(Fig. 5c), suggesting that N5, loop 5A and CDR5 restrict
MKK7ED activity to inhibition of stomatal development.
In contrast, MKK7ED-5B’s ability to cause stomatal
clustering and inhibition of stomatal development at
Fig. 4 N-termini link MKKs to their phenotypic outputs and the C-terminal Loop B is required for FAMA stage-specific regulation of MKK5. a–f Paired
micrographs of representative major phenotype (left) and subcellular localization (right), of specific MKK5DD- and MKK7ED-YFP variants (diagramed above).
Black brackets mark clusters and asterisks indicate inhibition. YFP is in green and cell outlines in magenta. For example, in (a) MKK5DD expression results
in a WT phenotype and the protein is cytoplasmic and in (b) mitochondrial/cytoplasmic N7-MKK5DD induces stomatal clustering. Mitochondria-localized
signals indicated with white arrowheads. Scale bars are 50 μm in phenotype images and 10 μm for localization images. g Quantification of phenotypes
in (a–f). h SPCH stage inhibition of lineage initiation. Error bars in (g) and (h) correspond to 95% confidence interval. i In vitro kinase activity towards
kinase inactive MPK3 and MPK6. Kinase assays were performed in triplicates, normalized to unphosphorylated KI-MPK and averaged; error bars represent
standard errors
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the FAMA stage was markedly reduced when
compared to MKK7ED (Fig. 5g). Because MKK7ED-5B
also showed reduced activities in other indicators of
MKK activity (Fig. 5h and i), we concluded that the
negative regulation of MKK5DD is restricted to loop
5B but cannot be transferred without affecting MKK7ED
catalytic activity. Nevertheless, the same results
highlight that loop 7B is required for robust MKK7ED
activity.
Swapping domains allows specificity to be changed in
MKK5DD and MKK7ED
Our results show that the N-terminus, CPR region (loops
A and B) and CDR region modulate MKK activity. We
Fig. 5 Loops A and B are required for specific and robust FAMA stage MKK7 activities. a–f Paired micrographs of representative major phenotype
(left) and subcellular localization (right), of specific MKK7ED-YFP variants diagramed above. Black brackets mark clusters and asterisks indicate inhibition.
YFP is in green and cell outlines in magenta; white arrowheads point to mitochondrial localization. For example, in (a) MKK7ED induces stomatal
clustering (brackets) and is mitochondrial localized (white arrowheads). Scale bars are 50 μm for phenotype images and 10 μm for localization images.
g Quantification of phenotypes in (a–f). h SPCH stage inhibition of lineage initiation. Error bars in (g) and (h) correspond to 95% confidence
interval. i In vitro kinase activity towards kinase inactive MPK3 and MPK6. Kinase assays were performed in triplicates, normalized to unphosphorylated
KI-MPK and averaged; error bars represent standard errors
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showed that N7 and CPR7 are necessary for MKK7ED-
mediated GC clustering at the FAMA stage, but when
CDR5 is incorporated into MKK7ED, GC production is
inhibited. If our “wiring diagram” for specificity is correct,
then a chimera that contains the GC promoting domains
from MKK7 but not the inhibitory CDR5 (i.e., N7-
MKK5DD-C7) should mimic MKK7ED. Indeed, when we
constructed N7-MKK5DD-C7, it resembled MKK7ED both
qualitatively and quantitatively (Fig. 6a and c). Likewise,
N5-MKK7ED-C5 should match MKK5DD activities, and it
does in planta (Fig. 6b and c). Interestingly, robust
rewiring in vivo (Fig. 6c and d) appears to be uncoupled
from kinase activity in vitro, as both rewired proteins were
much less capable of phosphorylating MPK3 and MPK6
than MKK5DD and MKK7ED (Fig. 6e). One interpretation
of these swaps is that specificity lies only outside of the
kinase domain. If this were true, then we should be able to
generate a chimera that resembles N7-MKK5DD-C7 and
MKK7ED using the kinase domain from another MKK.
We selected the kinase domain of MKK6 that can also
phosphorylate MPK3 and MPK6 in vitro [25], and created
N7-MKK6DD-C7. Expression of N7-MKK6DD-C7 at the
FAMA stage, however, did not produce any noticeable
phenotype (Additional file 5: Figure S6). This suggests that
although kinase domains in MKK5 and MKK7 are not
differential, they still contain stomatal fate-enabling regions.
Fig. 6 MKK5 and MKK7 activity and localization in the stomatal lineage can be reciprocally rewired. a–b Paired micrographs of representative major
phenotype (left) and subcellular localization (right), specific MKK-YFP variants diagramed above. Black brackets mark clusters; YFP is in green and cell
outlines in magenta; white arrowheads point to mitochondrial localization. a N7-MKK5DD-C7 mimics MKK7ED in that it produces clusters and can
localize to mitochondria. b N5-MKK7ED-C5 mimics MKK5DD in that it has a WT phenotype and localizes in the cytoplasm. Scale bars are 50 μm in
phenotype images and 10 μm for localization images. c Quantification of phenotypes (a–b). d SPCH stage inhibition of lineage initiation. Error bars in
(c) and (d) correspond to 95% confidence interval. e In vitro kinase activity towards kinase inactive MPK3 and MPK6. Kinase assays were performed in
triplicates, normalized to unphosphorylated KI-MPK and averaged; error bars represent standard errors
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Comprehensive analysis of chimeras reveals functions of
MKK domains
We repeatedly observed that the ability of native and
chimeric MKKs to phosphorylate their targets in vitro
does not predict their activities in vivo. In fact, when
chimera data are considered together, in vitro versus in
vivo data have no statistical correlation (Additional file 6:
Figure S7). In contrast, when only in vivo data were
compared, activities in SPCH and FAMA stages were
positively correlated (Fig. 7a). Interestingly, native and
chimeric MKKs were distributed in two subpopulations.
MKKs closer to the regression line promoted stomatal
clustering (red dots) or inhibited stomatal formation
(black dots). MKKs further from the regression line had
no effect in stomatal development at the FAMA stage
(blue dots), but had a broad range of activities at the
SPCH stage (shaded area in Fig. 7a). This behavior
might be reflecting the additional regulation that some
of the MKKs showed at the FAMA stage.
We reasoned that MKKs subject to the same regu-
lation would share structural similarities. To test this
hypothesis and generate an overall picture of the re-
lationship between MKK structural domains and in
vivo functions, we clustered 15 native and chimeric
MKKs and controls according to their quantitative
phenotype data at the FAMA stage (clustering de-
tailed in methods). Constructs robustly fell into
three clusters (Fig. 7b): Cluster 1, no phenotypic ef-
fect; Cluster 2, induces stomatal proliferation; and
Cluster 3, inhibits stomatal formation (the presumed
endogenous role for MKK5). Within clusters, how-
ever, not all MKKs were identical. We performed se-
quential tests of independence to determine how
similar the distribution of phenotype frequencies was
between chimeras in each cluster. Cluster 1 was
composed of MKKs similar to MKK5DD (group 1)
and MKKs similar to inactive YFP (group 2). Cluster
2 was statistically separated into weak MKK7ED-like
chimeras (group 3) and two MKKs that induced
strong clustering, yet were different from each other.
Cluster 3 was statistically separated into strong
inhibitors of stomatal formation (group 4) and weak
inhibitors (different from each other).
To summarize, when analyzing native and chimeric
MKK structures across Clusters, we see that loops A and
B have discrete functions in selecting MKK-specific out-
puts and in kinase activity in vivo. Loop A can be
thought of as a “channel selector”, that, together with
N-terminus and CDR, selects between the normal role
of arresting stomatal progression and the artificial role
of promoting stomatal clustering. Loop B is a “volume
control” with the 7B version increasing, and 5B de-
creasing, the phenotypes specified by the other domains
of the MKKs.
MPK6 mediates GC inhibition, but like MKK5, is prevented
from doing so at the FAMA stage
Previous loss- and gain-of-function experiments placed
MPK3 and MPK6 downstream of an activated MKK4/5
homologue (NtMEK2), suppressing stomatal formation
Fig. 7 MKK5 defines a cluster of chimeras with low activity at FAMA
stage, whereas clustering and inhibiting chimeras group in two
independent clusters. a SPCH and FAMA stage activities show a weak
positive correlation. Shaded area corresponds to activities at the FAMA
stage lower than 30%. Data points are colored according to the cluster
they belong to in (b). MKK activities at the FAMA stage are separated
into three clusters (b): cluster 1 contains MKKs that show no phenotypic
effect and contain loop 5B; cluster 2 contains MKKs that lead to
stomatal clustering and contain N7; and, cluster 3 contains MKKs that
lead to inhibition of stomatal development and contain loop 7B.
Numbers next to nodes correspond to approximately unbiased p-values
with bootstrap replications set to 1000. Chimeras not significantly
different in Chi-squared tests if independence are indicated with an
identical number (p> 0.05)
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[21] in the early stages of the stomatal lineage, but this
assay could not address the potential for MPK3 and
MPK6 to mediate FAMA-stage activities. Our chimeras
that drive stomatal inhibition at the FAMA-stage, how-
ever, could be used to see whether either mediated such
late stage inhibition. We used N5-MKK7ED which, in
WT led to complete inhibition of stomatal development
(Fig. 8a, Table 1). When expressed in the loss of function
mpk6-3 background, N5-MKK7ED failed to promote
complete inhibition in 19 independent T1 s (Fig. 8b)
indicating that MPK6 is likely downstream. This led us
to the question of whether MPK6, like MKK5DD, would
also be actively inhibited from effecting fate at the
FAMA stage. To test this, we created a constitutively
active MPK6 (MPK6DE) [33] and tested its ability to
suppress stomatal formation. Expression of MPK6DE
(but not MPK3DE; Fig. 8c, Table 1) inhibited stomatal
progression at the SPCH stage, indicating that MPK6DE
is active in this assay. When expressed at the FAMA stage,
however, MPK6DE did not affect stomatal development
(Fig. 8d, Table 1), a phenotypic output remarkably similar
to that of MKK5DD (early, but not late, inhibition). We
hypothesized that MKK5 and MPK6 normally repress
stomatal development, but are actively prevented from
having this effect at the FAMA stage.
Discussion
In multicellular organisms, coordinated development re-
quires constant communication between cells and the
evaluation of environmental conditions. All this informa-
tion is integrated to decide from a spectrum of possible
outputs, and the spectrum is frequently limited by a
cell’s identity. In previous, more superficial studies,
FAMA stage cells appeared to lose the ability to inhibit
stomatal development upon MAPK activation [22]. Here
we show that these cells do not lack the capacity to be
inhibited, but rather that MKK5 (and possibly MPK6)
may be actively prevented from participating in this cel-
lular outcome. Interestingly, from a cellular behavior
perspective, the inhibition of stomatal formation appears
Fig. 8 MPK6 inhibits stomatal development at the FAMA stage in a MKK-specific manner. a and b Micrographs indicating the requirement for
MPK6 as a downstream factor in N5-MKK7ED-mediated FAMA-stage inhibition (asterisks). In mpk6 mutants (b), stomata (arrowhead) coexist with
precursors that exit the lineage. (c and d) DIC micrographs showing results of expression of MPK6DE at SPCH and FAMA stages, stomata are
highlighted in green. MPK3DE does not affect development at any stage (Table 1). Scale bars in are 50 μm
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to be due to developmental reprogramming and not an
ROS-induced cell death (a response induced by CA-
MKKs in other contexts [34, 35]). In none of our ana-
lyses of leaves at seedling or mature plant stages did we
detect lesions typical of cell death, nor did we observe
the increased autofluorescence indicative of a burst of
ROS production. Seedling lethality resulting from MKK
manipulations under SPCH or FAMA promoters is likely
a result of carbon dioxide starvation due to lack of func-
tional stomata as these seedlings exhibit the pale, thin
leaves common in stomataless mutants [36].
Structural analysis and engineered chimeras revealed
that this regulation and other specific responses rely on
distinct MKK domains. We found that Arabidopsis
MKKs behave as modular proteins with four discrete re-
gions: N-terminus, CDR and two loops (A and B) in the
CPR. N-termini contribute to subcellular localization
(Fig. 4 and in [23]), to phenotypic output (Fig. 4) and
may mediate interactions with downstream MPKs through
their docking domains. In particular, we hypothesize
that N7 has the ability to bind different types of MPK.
Throughout development, MKK7 inhibits stomatal de-
velopment by recruiting MPK3/6, but a yet unknown
proliferative MPK mediates stomatal clustering at the
FAMA stage (Fig. 9a). In the C-termini, Arabidopsis
MKKs 1, 2, 4, 5 and 6 contain an extension that could
be equivalent to the MKKK-interacting domain for ver-
satile docking (DVD) in human MEKs 1, 3, 4, 6 and 7
(Additional file 4: Figure S4) [37]. Arabidopsis MKK7,
8, 9, and 10, however, lack this domain, making it un-
clear how they engage the appropriate MKKK. In fact,
the addition of CDR5 to MKK7ED restricted this kinase’s
activity to an inhibitory output (Fig. 5c and g), suggesting
that CDR5 interferes with MKK7ED interactions. Upstream
of the CDR, Loop A and B are two surface-exposed mod-
ules in the CPR that may contribute to establishing interac-
tions with other network components. In our experiments,
swapping loop A in MKK7ED restricted its phenotypic
output such that MKK7ED-5A only inhibited stomata
formation (Fig. 5e, g). We propose then, that loop A
promotes certain MKK-MPK interactions or, alternatively,
restricts how MPKs contact MKKs. This hypothesis is sup-
ported by sequence similarities between human MEKs that
share the same downstream MAPKs [1]. For example, ERK
kinases MEK1 and MEK2 have identical loop As, and
p38 kinases MEK3 and MEK6 differ at only one site
(Additional file 4: Figure S4). Interestingly, human MEK7,
which can phosphorylate both JNK and p38, shares some
residues with MEK3 and MEK6 and others with the JNK
kinase MEK4.
The function of loop B seems to be associated to MKK-
specific regulation. Our data shows that loop B is required
for robust MKK7ED activity, but it prevents MKK5DD-
mediated inhibition at the FAMA stage (Figs. 4f–g and
5f–g). Based on these phenotypes, we propose that loop B
mediates interactions with different scaffolds (Fig. 9). A
signal-promoting scaffold binds loop 7B and enforces
MKK7 interactions with its cognate MKKK and MPK
(Fig. 9a). Such a scaffold would also explain why in vivo
activity of MKK7ED was always stronger than that of
MKK5DD, even though in vitro assays showed an opposite
pattern. On the other hand, we predict that a distinct
scaffold recruited by loop 5B prevents MKK5DD from
inhibiting stomatal development at the FAMA stage
(inhibitory scaffold) (Fig. 9b). This prediction could also
partially explain the behavior of certain chimeras. For
example, the inhibitory scaffold would bind MKK7ED-5B
Fig. 9 A new model derived from activities during stomatal
development for the endogenous MKK5 pathway and another
activated by MKK7. a In the MKK7 pathway, MKK7 mimics MKK5 in
early development, forcing precursors to exit the stomatal lineage.
At the last stage, MKK7 induces two phenotypes. Firstly, MKK7
induces stomatal clustering by means of an unknown MKK7-specific
MPK (orange circle). This proliferation depends on MKK7 mitochondrial
localization [23]. Secondly, MKK7 forces precursors to exit the lineage
by escaping MKK5-specific regulation. An MKK7 scaffold enforces
interactions between MKK7 and other components (MPKs and YODA,
gray circles) within the network. b In the endogenous pathway, MKK5
and MPK3/6 (black circles) are involved in transducing developmental
signals that inhibit stomatal lineage initiation and GMC commitment,
and initiating defense and stress responses. At the last stage of
development, a stage-specific MKK5 scaffold prevents MKK5 (and
possibly MPK3/6) from inhibiting stomatal formation, only allowing
defense and stress responses
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through loop 5B and dampen MKK7ED activities. Likewise,
a signal-promoting scaffold would bind MKK5DD-7B
through loop 7B, releasing the inhibition of MKK5DD.
The existence of signal-enhancing and inhibiting
MAPK scaffolds in plants is supported by recent findings
[38–40]. While the relevance of the first type is quite in-
tuitive, the second type is more controversial. The in-
hibitory scaffold EDR1 was identified in the context of
pathogen defense. Current hypotheses are that EDR1
provides a failsafe against inadvertently activating defense
or cell death programs when other (not pathogen-
induced) cues activate MAPK signaling. EDR modulates
MPK3 activity indirectly by interacting with MKK4/5 and
regulating their abundance [38]. Interestingly, we observed
in FAMA stage cells that MPK6 was only inhibited when
the upstream MKK was also inhibited. The clearest evi-
dence that MKK5-MPK3/6 are scaffolded in FAMA stage
cells would be, of course, to identify the scaffold. We
tested whether EDR1 worked to inhibit FAMA-stage
expressed MKK5DD, however we failed to see a loss of
inhibition in edr1 (none seen in 20 independent T1 s).
EDR1 is a member of the large Raf-like MKKKs family
[41] and potentially any of the 48 members of this family
(alone or in combination) could serve as a stomatal
scaffold. As testing the entire family in not technically
feasible, we used stomatal lineage expression data [26]
to identify two close homologues of EDR1 expressed at
the FAMA stage, MAP3Kδ1 (At1g11850) and MAP3Kδ5
(At4g24480). MAP3Kδ1 and MAP3Kδ5 mutants, however,
were indistinguishable from WT in their response to
FAMA stage MKK5DD expression (0/20 independent T1 s
for each). Thus, the molecular identity of the stomatal
scaffold remains of great future interest.
Conclusions
MKK4/5 face the problem of being used in early stages
to repress stomatal progression, but being required for
physiological regulation in guard cells. At the FAMA
stage, MKK4/5 must therefore be actively rerouted from
their previous role inhibiting stomatal development to
allow terminal differentiation of guard cells (Fig. 9). A
negative scaffold acting late in the stomatal lineage to re-
direct MKK4/5 would provide an elegant solution to a
complex signal integration problem.
Methods
Plant material and growth conditions
All transgenic lines were generated in the Col-0 back-
ground. Seeds were plated on half-strength Murashige-
Skoog media containing 1% agar-agar (Caisson Labora-
tories, North Logan, UT) and 100 μg/ml Kanamycin
(Sigma-Aldrich) or 50 μg/ml Hygromycin B (Life Tech-
nologies) when appropriate. Seedlings were grown under
a light intensity of 100 μmol photons m− 2 s− 1 in a 16:8
photoperiod at 22 ± 1 °C. Analyses were performed in
15 day after germination (dag) cotyledons unless stated
otherwise. The mpk6-3 allele was Salk_127507 [42].
Mutant alleles for EDR1 (Salk_127158), MAP3Kδ1 (Salk_
048985) and MAP3Kδ5 (Salk_029929 and Salk_036615)
were obtained from the ABRC.
Multiple sequence alignment and structural analysis
Selected mammalian kinases were aligned using Clustal
Omega [43] and structural models are in Additional file 3:
Figure S3B. MKK5 and MKK7 structural predictions were
performed with I-Tasser [27], using MEK1 (1S9J) to assist
the prediction. Models were explored with Swiss-
PdbViewer v4.1 and fit with the Magic Fit button [44].
Structural features were extracted from models and
overlaid on the primary sequence (Additional files 3, 4
and 7: Figures S3–S5).
Construction of constitutively active MKK and synthetic
chimeras
Domain swap constructs were assembled by fusion PCR
from DNA amplicons (blocks) generated with Phusion®
High-Fidelity DNA Polymerase following manufacturer’s
instructions (New England Biolabs, Ipswich, MA). To
generate blocks, MKK5DD and MKK7ED cloned into
pENTR without stop codons or other chimeras were
used as templates [22]. Blocks were designed to contain
attL1 and attL2 functional sequences from pENTR to
ease the cloning procedure through the Gateway
strategy (Additional file 8). For domain swaps assembled
from two blocks, 5′ blocks contained the M13 forward
priming site and attL1 recombination site before the
MKK sequence; and 3′ blocks contained the MKK
sequence followed by attL2 recombination site and M13
reverse priming site. To facilitate fusion of the blocks,
reverse primers for 5′ blocks and forward primers for 3′
blocks were designed as chimeras of the two blocks to
be fused, containing at least 15 bases from each block,
and were completely complementary to each other. PCR
products were gel extracted using QIAquick Gel
Extraction Kit (QIAGEN Inc., Valencia, CA) and 1:1 M
ratio mix were used as templates on fusion PCR reactions
using M13 forward and reverse primers. Domain swap
constructs were gel purified and cloned into pJET 1.2
according to CloneJET PCR Cloning Kit instructions
(Thermo Life Sciences, Pittsburgh, PA). For domain swap
constructs assembled from 3 blocks, 5′ and 3′ were
generated with the same strategy as above, while internal
block was amplified with forward and reverse chimeric
primers. As domain swaps became more elaborate, first
domain swap constructs were used as templates for
generating new blocks. Primers, templates and sequences
for each domain swap are listed in Additional file 8:
Table S1, A and B.
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To build constructs for expression under SPCH and
FAMA promoters, 2.5-kb fragments previously described
[36, 45] were first adapted to the Multisite Gateway
system. Promoters were shuttled from pENTR to
pDONR P4 P1R (Life Technologies, Grand Island, NY)
by PCR amplification using promoter shuttling primers
(Additional file 8) followed by BP recombination per-
formed under manufacturer’s instructions. Promoters
flanked by attL4 and attR1 recombination sites
(pDONR-promoter) were used in Multisite recombin-
ation reactions with domain swap constructs in pJET
and R4pGWB440 [destination vector carrying the Gate-
way cassette flanked by attR4 and attR2 recombination
sites, in frame C-terminal fusion to enhanced YFP and
kanamycin selection in plants [46]]. Recombination re-
actions were performed in a two-step protocol. First,
1 μl of LR Clonase II was added to 4 μl vector mix
(containing 150 ng of pDONR-promoter and 150 ng
pJET-domain swap construct) and incubated at 25 °C
for 5 h. Then, 150 ng of R4pGWB440 in 4 μl solution
were added to the reactions along 1 μl of LR Clonase
II. Reactions were incubated for additional 16 h at 25 °
C and then stopped after the addition of 1 μl of Pro-
teinase K and incubation for 10 min at 37 °C. Con-
structs were confirmed by sequencing and introduced
in Arabidopsis by Agrobacterium tumefaciens-mediated
transformation.
Mutants edr1, map3kδ1 and map3kδ5 were transformed
with FAMApro:MKK5
DD in pHGY, previously used in [22].
MPK3 and MPK6 clones were provided by Jean Colcombet
(INRAVersailles-Grignon, France) [33].
Scoring phenotypes and data analysis
Seedlings (15 dag) were fixed in 7:1 ethanol:acetic acid,
and cleared in Hoyer’s medium. Cotyledons were imaged
by differential interference contrast microscopy on a Leica
DM2500 microscope at × 20 magnification (0.320 mm− 2
field of view). One picture per independent transgenic
seedling was taken from the distal tip of the cotyledons,
within the vascular loop, on the abaxial epidermis.
Phenotypes at the FAMA stage were as follows: (1)
normal phenotype, only single stomata with tolerance
for 1 stomatal cluster per field of view; (2) stomatal
inhibition, no stomata present or inhibited precursors
coexisted with normal stomata and appeared in at least
two independent fields of view per sample; (3) large
stomatal cluster, at least two stomatal clusters (4 or
more stomata in contact) per field of view; (4) small
stomatal cluster, clusters contained 2–3 stomata in
contact. When a sample contained a mixed population
of clusters, the presence of large clusters defined the
classification for this category. MKK7ED, clusters were
systematically bigger than any chimera and often were
delayed in development; to confirm clustering, older
epidermis (near apical hydathode or in older plants)
was scored. SPCH stage phenotypes were quantified as
(1) inhibited (no stomata per field of view) or (2) not
inhibited (2 or more stomata per field of view). To
enable us to score phenotypes in T1 seedlings that
must be grown on antibiotic selection, we grew 35S:
YFP lines with the same antibiotic resistance as the
MKK variants under the same conditions and scored
these as the equivalent of WT controls.
A binomial distribution for phenotypic data was as-
sumed and the percentages of each phenotype were cal-
culated with a confidence of 95%. This analysis is similar
to others done on data of comparable nature [47]. Linear
regressions between in vitro and in vivo data; and be-
tween SPCH and FAMA data in Fig. 7 and Additional
file 6: Figure S7 were done with Microsoft Excel. To
cluster chimeras, hierarchical clustering was performed
on phenotypic data at the FAMA stage using the func-
tion pvclust in the statistical software R. Percentages of
each one of the four phenotypes -Inhibited, Normal,
Small Clusters and Large Clusters- were converted to
frequencies (e.g. dividing by 100). The distance matrix
was obtained by calculating the dissimilarities between
all chimeras in their four phenotypes with the Manhat-
tan method. Clustering was performed with the ward.d
method and the number of bootstrap replications was
1000. To statistically determine how similar chimeras
were within clusters, a Chi-squared test of independence
was implemented to compare phenotype distributions.
Frequencies were compared to YFP (inactive), MKK5DD,
MKK7ED (inhibition of stomatal formation and stomatal
clustering) and N5-MKK7ED (strong stomatal inhibition).
Chimeras that were not statistically different are noted
with the same number in Fig. 7b. Unnumbered chimeras
were statistically different from the rest (p < 0.05).
To test the role of selected MAP3Ks as putative nega-
tive scaffolds of MKK5DD-mediated signaling at the
FAMA stage, T1 seeds for wild type (Col) and mutants
edr1, map3kδ1 and map3kδ5 carrying FAMApro:MKK5
DD
were plated on agar-solidified half-strength Murashigue-
Skoog media in the presence of 50 μg/ml Hygromycin B,
and screened for stomatal lineage inhibition using bright
field microscopy.
Confocal microscopy
Confocal images were collected using a Leica SP5 con-
focal microscope with excitation/emission spectra of
514/520 to 540 for YFP and 565/580 to 610 for propi-
dium iodide counterstaining. ImageJ (NIH) was used to
build Z-stacks from confocal images. To improve reso-
lution of cell outlines, layers were summed rather than
averaged. Z-stacks were then split into single channels
and only the channel for the cell outlines was conserved,
transformed into a grey-scale image and colors were
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inverted. Bright and contrast were modified to improve
image quality. For localization, color channels in Z-
stacks were maintained and images were cropped.
Localization of MKK-YFP chimeras was investigated in
stable (T2-T3) lines with the exception of chimeras that
induced stomatal inhibition, where localization was de-
termined in T1 s on antibiotic selection.
Kinase-inactive MPK3 and MPK6 phosphorylation
In vitro kinase assays to assess the ability of MKK vari-
ants to phosphorylate either kinase inactive (KI) MPK3
or MPK6 were performed as described in [23]. KI-MPKs
were used to avoid autophosphorylation of the sub-
strates. Band intensity was detected and analyzed using
ImageJ (NIH). Each reaction was performed in triplicate.
The ratio of phosphorylated KI-MPK/unphosphorylated
KI-MPK detected by p42/44 antibody (Cell Signaling,
Cat. No. 9102) was used to estimate MKK activity. Be-
cause this study is focused on regions in MKK5 and
MKK7 responsible for differential activity, it was critical
to be able to compare them side-by-side. For this reason,
each replicate of the kinase assay was performed on all
samples using the same “master mix”, run on the same
gel and blotted and probed together. To quantify MKK
activities, the background signal intensities of unpho-
sphorylated KI-MPKs were first subtracted from all sam-
ples within experiments. Because different experiments
showed different signal intensities, signals were normal-
ized to MKK5DD’s (thus, defined as 100% kinase activ-
ity) within each experiment. Values for each MKK were
then averaged across experiments and standard errors
were calculated. Samples that showed “ghost bands” were
eliminated from the analysis (see red boxes in Additional
file 2: Figure S2).
Yeast two-hybrid assays
Yeast two-hybrid assays was performed with the match-
maker Two-Hybrid System 3 (Clontech) using a modi-
fied set of plasmids compatible with Gateway technology
and conditions specified by the manufacturer. MKKs
and chimeras were cloned as DNA Binding Domain fu-
sions and MPKs were cloned as Activation Domain fu-
sions. Three independent yeast colonies were tested for
each pairwise comparison at 1, 1:10 and 1:100 dilutions
after incubation of 2, 3 and 4 days in plates containing
1 mM 3-amino-1/2/4-triazole. Experiments were re-
peated three times with yeast cultures at OD600 of 1, 2
and 4. Interactions were evaluated as positive if signifi-
cant growth was detected in 1:100 dilution at day 3.
Accession numbers
Arabidopsis Genome Initiative locus identifiers for the
genes studied in this work are: SPCH, AT5G53210;
FAMA, AT3G24140; MKK5, AT3G21220; MKK6,
AT5G56580; MKK7, AT1G18350; MPK3, AT3G45640;
MPK6, AT2G43790; EDR1, AT1G08720; MAP3Kδ1,
AT1G11850; MAP3Kδ5, AT4G24480.
Additional files
Additional file 1: Figure S1. Yeast two-hybrid assay with native and
chimeric MKKs and MPK3/MPK6. Representative yeast two-hybrid assay
between MKK chimeras and MPK3/6 at 3 days of growth on control (-LW) and
interaction (-LWH); three patches are serial (10 fold) dilutions. (JPEG 607 kb)
Additional file 2: Figure S2. In vitro kinase assays of MKKs and chimeras
using kinase inactive (KI) MPK3 and MPK6 as substrates. Phosphorylation
assays were performed as described in methods. Samples were separated in
SDS-PAGE, transferred to PVDF membranes and probed with anti-pERK
antibody. Western blots were quantified and average of experiments
was used as an estimation of in vitro activity. Each lane is labeled with
the figure where the data is presented (grey bar marked Figures), the
kinase used with a graphic representation and with its full name in bottom
panel. Samples unassigned to any figure (labeled as “-” in Figure) were not
presented in the main figures of this manuscript for the sake of brevity, but
are included here to allow us to keep the blots intact. Red squares highlight
samples that were not considered for quantification due to detection
artifacts. (JPEG 565 kb)
Additional file 3: Figure S3. Multiple sequence alignment [43] of
catalytic domains in MPK kinases from mouse, rat, human and Arabidopsis
thaliana. A, Conserved subdomains (Subdom.) and consensus sequences
(Consen.) are represented on top of the alignment and follow the same
codes and convention for an alignment of 60 different kinases by Hanks
and Hunter [28]. In the consensus line: uppercase letters, invariant residues;
lowercase residues, nearly invariant residues; o, positions conserving nonpolar
residues; *, positions conserving polar residues; +, positions conserving small
residues with near neutral polarity. Mammalian representative kinases
selected for the alignment have been crystalized and belong to AGC group
[cAMP-dependent kinase, cGMP-dependent kinase, etc.], CAMK group
[Calcium-calmoduline-dependent protein kinase], CMGC group [cyclin-
dependent kinase, mitogen-activated kinase, glycogen synthase kinase
and cyclin-dependent-like kinase] and STE group [homologues of
STE11 and STE20]. Gray boxes show CMGC insert [30] in ERK2, CDK2
and p38, and Pro-rich sequence (PRS, involved in binding the scaffold
MP1) in MEK1 and MEK2 were included in the alignment and cause an
expansion of subdomain X. Secondary structure (2° str.) information is
overlaid in the alignment (red for α-helices and yellow for β-strands).
Conserved α-helices and β-strands are labeled following convention
[28, 31]. Due to CMGC insert and PRS, αG helix is located in two different
regions of the alignment and was named differently (residues underlined):
αG1 for MmPKA, HsARK-1, RnCaMKI, RnERK2, HsCDK2 and Hsp38; and αG2
for HsMEK1/2 and AtMKK5/7. In green text, missing residues in crystal
structures from HsMEK1 and HsMEK2 which include the PRS. B, Table
provides general information and structural model names for kinases used
in this comparison. C, Multiple sequence alignment of N- and C-termini
from human MEK1/2 and Arabidopsis MKK5/7. Sequences highlighted in
gray correspond to first and last three amino acids of the catalytic domains
shown in A. (JPEG 1120 kb)
Additional file 4: Figure S4. Multiple sequence alignment of C-termini
in Arabidopsis and human MKKs. Top panel, partial sequences for all
Arabidopsis and human MKKs were aligned with ClustalOmega. Loops
A and B defined for Arabidopsis MKKs are highlighted in gray. Number
of first amino acid of the partial sequence is noted to the left of each
sequence. The long C-terminal extension of AtMKK3 is truncated in this
figure. Bottom panel, genes used in the alignment. Name of genes for
Arabidopsis correspond to Arabidopsis Genome Initiative (AGI) codes and
GeneCards (GC) for humans. NCBI GI, National Center for Biotechnology
Information protein sequence identifier. (JPEG 1010 kb)
Additional file 5: Figure S6. Representative phenotype and subcellular
localization of transgenic seedlings expressing FAMAp:N7-MKK6EE-C7.
(JPEG 465 kb)
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Additional file 6: Figure S7. In vitro kinase activity of MKKs does not
correlate with their in vivo activity. Linear regressions for MPK3 or MPK6
activity versus SPCH stage (A) or FAMA stage (B) activities, with their
formulas and R2, are displayed in the figure. FAMA stage activity was
calculated as the addition of phenotypes different than normal (Inhibited,
Small and Large clusters in Table 1). (JPEG 505 kb)
Additional file 7: Figure S5. Multiple sequence alignment for MKK4,
MKK5, MKK7 and MKK9. Domains described in [23] are highlighted in
blue and green. (JPEG 779 kb)
Additional file 8: Oligonucleotides sequences used in this paper,
cloning strategy and protein sequence of chimeras. (DOCX 39 kb)
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